Publication | Closed Access

Identification of novel serum biomarker for the detection of acute myeloid leukemia based on liquid chromatography-mass spectrometry

Hematological MalignancyEngineeringNovel Serum BiomarkerMedicineAcute Myeloid LeukemiaBioanalysisMass SpectrometryImmunologyPathologyHematologyLiquid Chromatography-mass SpectrometryMixed-phenotype Acute LeukemiaAnalytical ChemistryBiomarker DiscoveryClinical ChemistryMolecular DiagnosticsChromatographyMyeloid Neoplasia